MK-677 (Ibutamoren) Super-Responder Profile: Who Gets the Best Results and Why MK-677 (Ibutamoren) Profile of Super-Responders: Who Gets the Best Results At a glance Drug class / oral ghrelin-receptor agonist (growth hormone secretagogue) Typical clinical dose / 10 to 25 mg orally once daily at bedtime Peak IGF-1 response window / 4 to 12 weeks of continuous use Super-responder IGF-1 threshold / greater than 60% rise from baseline Key predictor 1 / low baseline IGF-1 (below 150 ng/mL in adults) Key predictor 2 / age under 40, especially under 30 Key predictor 3 / consistent dosing with high-protein diet (1.6+ g/kg/day) Main risk in super-responders / water retention, transient insulin resistance Regulatory status / not FDA-approved
Obesity rarely arrives alone heart failure, kidney disease, diabetes, hypertension are usually close by
467 Under hyperglycemic conditions, GLP-1RAs regulate hypertension by inhibiting carotid body function
Nutrient deficiencies Appetite suppression could lead to reduced calorie and nutrient intake, which is crucial for a healthy pregnancy
At Arsenault Aesthetics, we offer treatments that can help boost your glutathione levels
All prescribing decisions are made solely by their licensed clinicians